Erlotinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition
Mappings
NCI Thesaurus: Erlotinib (coding:ncit:C65530)
RxNorm: erlotinib (coding:rxcui:337525, coding:omop:4185613)
SNOMED: Erlotinib (coding:sctid:414123001, coding:omop:1325363)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Erlotinib | |
| FDA (1) | EGFR p.L858R | Non-Small Cell Lung Cancer | Erlotinib | |
| FDA (1) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab | |
| FDA (1) | EGFR p.L858R | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab |